# Clinical Validation of the NowFuture Digital Flu / COVID Test in Anterior Nasal Samples for Over-the-Counter (OTC) Use in Australia

> **NCT07743970** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Biocrucible Ltd** · enrollment: 500 (estimated)

## Conditions studied

- SARS CoV 2 Infection
- Influenza A Virus Infection
- Influenza B Virus Infection

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic test for SARS-CoV-2, influenza A and influenza B

## Key facts

- **NCT ID:** NCT07743970
- **Lead sponsor:** Biocrucible Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-08-17
- **Primary completion:** 2026-10
- **Final completion:** 2027-04
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743970, "Clinical Validation of the NowFuture Digital Flu / COVID Test in Anterior Nasal Samples for Over-the-Counter (OTC) Use in Australia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*